Catalent Maryland
✓ Verified ManufacturerAbout
Catalent Maryland operates as a leading Contract Development and Manufacturing Organization specializing in advanced pharmaceutical manufacturing and gene therapy solutions at its Baltimore facility. Located at the University of Maryland BioPark, the state-of-the-art 128,000 square foot facility focuses on upstream and downstream process development of viral vectors for clinical applications, supporting transformative technologies including AAV vectors, vaccines, and oncolytic immunotherapies. The company provides comprehensive CDMO services including process development, formulation, bioavailability enhancement, clinical supply manufacturing, and regulatory support for pharmaceutical and biotechnology companies worldwide. Their Baltimore operations feature CGMP cleanroom suites designed for Phase 1 and Phase 2 programs, equipped with cutting-edge biotechnology infrastructure and analytical testing capabilities. Catalent Maryland also operates additional facilities at the nearby Harmans BWI campus, featuring FDA and EMA approved manufacturing suites totaling over 345,000 square feet of production space. These facilities support Phase 3 through commercial manufacturing of advanced therapeutic products, with specialized cold storage warehousing and fill-finish capabilities. The organization leverages decades of pharmaceutical manufacturing expertise to accelerate drug development timelines while maintaining the highest quality standards and regulatory compliance. Their integrated approach combines innovative delivery technologies with scalable manufacturing solutions, enabling clients to advance life-changing medicines from early development through commercial production. Catalent Maryland serves as a critical hub for gene therapy manufacturing in the Mid-Atlantic region, supporting the growing demand for advanced therapeutic modalities.